Biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics

Ended Awarded Last action

Contract number
75F40121F19002
Awardee
Awarding agency
Obligated
$15,767,951

Award facts

Opportunity
  • RFTOP1242459 Solicitation number
Contract value 100% obligated
$15,767,950.67 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Hartford, CT 06156, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$1,032,665
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Exercise an Option P00004 · Exercise option YR 2: biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics $6,723,229
Other Administrative Action P00003 · Deobligate unexpended prior year funds: biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics -$710,194
Other Administrative Action P00002 $0
Exercise an Option P00001 $5,803,464
Original award $4,984,116

About this award

The Food and Drug Administration issued a delivery order to CVS Healthspire Payor & Life Sciences LLC on September 30, 2021, with a ceiling value of $15.77 million, under the BEST Initiative – Data Sources for Surveillance of Biologics IDIQ for healthcare data analytics and post-market surveillance of biological drugs.

Place of performance is Hartford, CT. The order was priced on a time and materials basis with an ultimate completion date of June 29, 2025. The BEST Initiative is a multiple-award FDA IDIQ supporting healthcare data sources and safety analysis for surveillance of biological products.

In the most recent reported fiscal year (FY2024), the order consumed 7.0 FTEs across 14,619 contractor hours, generating $3.9 million in invoiced labor. The derived government-paid hourly rate was $264.98/hr. CVS Healthspire self-performed all reported hours with no subcontractors. Across FY2022–FY2024, the order's labor footprint trended downward: FY2022 invoiced $4.3 million on 0.9 FTEs; FY2023 peaked at $4.2 million on 9.6 FTEs; FY2024 declined to $3.9 million on 7.0 FTEs.

Quick answers

Who was awarded contract 75F40121F19002?

75F40121F19002 was awarded to CVS Healthspire Payor & Life Sciences LLC by Food and Drug Administration (Department of Health and Human Services) on September 30, 2021.

How much is contract 75F40121F19002 worth?

The government has obligated $15,767,951 on 75F40121F19002.

Is contract 75F40121F19002 an order under another contract?

Yes. 75F40121F19002 is a delivery order under 75F40120D00028, an indefinite delivery contract, on BEST Initative - Data Sources For Surveillance of Biologics.

Was contract 75F40121F19002 competed?

The extent of competition for 75F40121F19002 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award